Dear Colleagues, Dear Friends, Dear Everyone,

Gortec has experienced and continues to maintain a strong momentum in its clinical trials over the past few years, some of which are unique, others innovative, and some strategic.
The NIVO-POSTOP study will change practices, with communications planned for 2025.
The biannual meetings of the ENT intergroup provide opportunities to share progress and discuss new projects, with representation from the professions involved in the management of head and neck carcinomas.

Dear colleagues, dear friends,

Clinical research is becoming increasingly complex with more constraints for investigators, stricter regulations, and exponentially growing costs for sponsors. In this context, it is essential to preserve and strengthen our academic research potential, particularly through cooperative oncology groups.